close

Freebase is currently in read-only mode

Topic

Created by fda_medical_bot on 1/7/2012

Anakinra 149.254 injectable solution ^en

mid: /m/0hqtgn0 notable type: /medicine/drug_formulation notable for: /medicine/drug_formulation

Anakinra injectable solution, for subcutaneous administration, consisting of: 149.254mg/mL anakinra.Indications:Kineret is an interleukin-1 receptor antagonist indicated for reduction in signs and symptoms and slowing the progression of structural damage in moderately to severely active rheumatoid arthritis, in patients 18 years of age or older who have failed 1 or more disease modifying antirheumatic drugs (DMARDs) (1) [ - ]

Add type

Metaweb System Types

Object

Common

Topic

Medicine

Drug formulation

Freebase

Object profile

Object is not asserted on this topic.

ID /type/object/id

-

GUID /type/object/guid

#9202a8c04000641f800000001f6cba80

Type /type/object/type

Drug formulation
Topic

Name /type/object/name

- - Edit
  - Delete
Anakinra 149.254 injectable solution

Key /type/object/key

- - Edit
  - Delete
/base/medicaldrugs/fda_load/form_9013DUQ28K_149_254mg_mL_injectable_solution_subcutaneous

Timestamp /type/object/timestamp

Saturday, January 07, 2012 8:28 AM

Permission /type/object/permission

/boot/all_permission

Creator /type/object/creator

fda_medical_bot

Attribution /type/object/attribution

fda_medical_bot

Search /type/object/search

-

Machine ID /type/object/mid

/m/0hqtgn0

Also known as /common/topic/alias

-

Description /common/topic/description

- - Edit
  - Delete
Anakinra injectable solution, for subcutaneous administration, consisting of: 149.254mg/mL anakinra.Indications:Kineret is an interleukin-1 receptor antagonist indicated for reduction in signs and symptoms and slowing the progression of structural damage in moderately to severely active rheumatoid arthritis, in patients 18 years of age or older who have failed 1 or more disease modifying antirheumatic drugs (DMARDs) (1)

Image /common/topic/image

-

Official website /common/topic/official_website

-

Topic equivalent webpage /common/topic/topic_equivalent_webpage

-

Social media presence /common/topic/social_media_presence

-

Topical webpage /common/topic/topical_webpage

-

Subjects /common/topic/subjects

-

Subject of /common/topic/subject_of

-

Web Link(s) (deprecated) /common/topic/webpage

-

Properties /common/topic/properties

-

Article /common/topic/article

<p>Anakinra injectable solution, for subcutaneous administration, consisting of: 149.254mg/mL...

Weblink /common/topic/weblink

-

Notable for /common/topic/notable_for

Drug formulation

Notable types /common/topic/notable_types

Drug formulation

Active ingredients /medicine/drug_formulation/active_ingredients

Anakinra

Strength /medicine/drug_formulation/strength

Strength value	Strength units	Active ingredient	Drug formulations available in this strength
Edit Delete View CVT 149.3	mg/mL	Anakinra	-

Dosage form /medicine/drug_formulation/dosage_form

Injectable solution

Routes of administration /medicine/drug_formulation/routes

Subcutaneous injection

Brand names /medicine/drug_formulation/brand_names

- - Edit
  - Delete
Kineret

Drug category /medicine/drug_formulation/drug_category

Biologic

Formulation of /medicine/drug_formulation/formulation_of

Anakinra

Active ingredient moieties /medicine/drug_formulation/active_ingredient_moieties

Anakinra

Active moieties (deprecated) /medicine/drug_formulation/active_moieties

-

Pregnancy category /medicine/drug_formulation/pregnancy_category

-

Legal status /medicine/drug_formulation/legal_status

Prescription drug

Manufactured forms /medicine/drug_formulation/manufactured_forms

Kineret 100 injectable solution

Reference form /medicine/drug_formulation/reference_form

-

Object profile is not asserted on this topic. Assert type now.

Object generation time /freebase/object_profile/object_generation_time

- - Edit
  - Delete
Friday, May 24, 2013 9:28 AM

Link count /freebase/object_profile/link_count

-

Comments

Hide